• Policy
• Lee wants to cover infertility, contraception, HPV vaccines
• by Lee, Jeong-Hwan Jan 11, 2022 06:29am

• Policy
• Alopecia belongs to the health sector, benefits are possible
• by Lee, Jeong-Hwan Jan 11, 2022 06:29am

• Policy
• 22 companies' Dapagliflozin+Sitaglipin were approved
• by Lee, Tak-Sun Jan 11, 2022 06:28am

• Policy
• Chong Kun Dang applied for combination of Januvia+Forxiga
• by Lee, Tak-Sun Jan 10, 2022 11:40am

• Policy
• Will companies be able to apply for EUA for COVID-19 tx?
• by Lee, Tak-Sun Jan 10, 2022 05:55am

• Policy
• Remdesivir has been officially granted over the age of 12
• by Lee, Tak-Sun Jan 10, 2022 05:55am

• Policy
• PAGs request expedited new drug listing system to candidates
• by Kim, Jung-Ju Jan 10, 2022 05:55am

• Policy
• Dong-A ST applied for Forxiga's Prodrug license
• by Lee, Tak-Sun Jan 7, 2022 06:06am

• Policy
• An additional purchase contract of pfizer tx has been signed
• by Kim, Jung-Ju Jan 7, 2022 06:06am

• Policy
• Is the KRAS gene-targeted drug also released in Korea?
• by Lee, Tak-Sun Jan 6, 2022 06:09am